Document is current
Any future updates will be listed below
-
Authors
Rohde, Monica M.
Snyder, Christina M.
Sloop, John
Solst, Shane R.
Donati, George L.
Spitz, Douglas R.
Furdui, Cristina M.
Singh, Ravi https://orcid.org/0000-0003-0750-1804
-
Funding
Funding for this research was provided by:
National Cancer Institute (R01CA207222, R33CA177461, P01CA217797, R01CA18280, P30CA012197, P30CA086862)
National Institute of General Medical Sciences (T32GM127261)
- License Information
-
More Information
Article History
Received: 17 April 2021
Accepted: 21 September 2021
First Online: 14 October 2021
Declarations
:
: Not applicable.
: Not applicable.
: RS has filed for protection of intellectual property relating to molecular signatures predictive of cancer sensitivity to silver nanoparticles (WO 2018/231790 Al). CMF is co-founder of Xoder Technologies, LLC, which provides consulting services and commercializes reagents for redox investigations.
